Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 3782-3795

  Lorquet, Sophie ^a,b   Berndt, Sarah ^a   Blacher, Silvia ^a   Gengoux, Emily ^a   Peulen, Olivier ^a   Maquoi, Erik ^a   Noël, Agnès ^a   Foidart, Jean Michel ^a,b   Munaut, Carine ^a   Péqueux, Christel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

eNOS; Mural cell migration; NO; S1P1; Vessel normalization

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; SPHINGOSINE 1 PHOSPHATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CULTURE MEDIUM; PRIMER DNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CELL MATURATION; CELL MIGRATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; VASCULAR RING; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CULTURE MEDIUM; GROWTH, DEVELOPMENT AND AGING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SOLUBILITY;

ANIMALS; BASE SEQUENCE; BLOOD VESSELS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; HUMANS; MICE; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77957833770     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-149070     Document Type: Article

References (50)

1. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
2. Jain, R. K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62
3. Sullivan, R., and Graham, C. H. (2007) Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26, 319-331
4. Fukumura, D., and Jain, R. K. (2007) Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res. 74, 72-84
5. Gerhardt, H., and Semb, H. (2008) Pericytes: gatekeepers in tumour cell metastasis? J. Mol. Med. 86, 135-144
6. Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y. M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., De Smet, F., Vinckier, S., Aragones, J., Debackere, K., Luttun, A., Wyns, S., Jordan, B., Pisacane, A., Gallez, B., Lampugnani, M. G., Dejana, E., Simons, M., Ratcliffe, P., Maxwell, P., and Carmeliet, P. (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851
7. Chabottaux, V., Ricaud, S., Host, L., Blacher, S., Paye, A., Thiry, M., Garofalakis, A., Pestourie, C., Gombert, K., Bruyère, F., Lewandowsky, D., Tavitian, B., Foidart, J.-M., Duconge, F., and Noël, A. (2009) A membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vascular architecture. J. Cell. Mol. Med. 13, 4002-4013
8. Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., and Jain, R. K. (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64, 3731-3736
9. Winkler, F., Kozin, S. V., Tong, R. T., Chae, S. S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., Munn, L. L., and Jain, R. K. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6, 553-563
10. Bergers, G., and Hanahan, D. (2008) Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592-603
11. Jain, R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693
12. Armulik, A., Abramsson, A., and Betsholtz, C. (2005) Endothelial/ pericyte interactions. Circ. Res. 97, 512-523
13. Andrae, J., Gallini, R., and Betsholtz, C. (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276-1312 (Pubitemid 351717519)
14. Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., and Fukumura, D. (2005) NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 115, 1816-1827
15. Peters, S. L. M., and Alewijnse, A. E. (2007) Sphingosine-1- phosphate signaling in the cardiovascular system. Curr. Opin. Pharmacol. 7, 186-192
16. Allende, M. L., and Proia, R. L. (2002) Sphingosine - phosphate receptors and the development of the vascular system. Biochim. Biophys. Acta 1582, 222-227
17. Kono, M., Mi, Y., Liu, Y., Sasaki, T., Allende, M. L., Wu, Y. P., Yamashita, T., and Proia, R. L. (2004) The sphingosine-1- phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279, 29367-29373
18. Shibuya, M. (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39, 469-478
19. Swendeman, S., Mendelson, K., Weskamp, G., Horiuchi, K., Deutsch, U., Scherle, P., Hooper, A., Rafii, S., and Blobel, C. P. (2008) VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ. Res. 103, 916-918
20. Ebos, J. M., Bocci, G., Man, S., Thorpe, P. E., Hicklin, D. J., Zhou, D., Jia, X., and Kerbel, R. S. (2004) A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol. Cancer Res. 2, 315-326
21. Kou, B., Li, Y., Zhang, L., Zhu, G., Wang, X., Li, Y., Xia, J., and Shi, Y. (2004) In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment. Exp. Mol. Pathol. 76, 129-137
22. Jacobi, J., Tam, B. Y., Wu, G., Hoffman, J., Cooke, J. P., and Kuo, C. J. (2004) Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia. Circulation 110, 2424-2429 (Pubitemid 39407349)
23. Szentirmai, O., Baker, C. H., Bullain, S. S., Lin, N., Takahashi, M., Folkman, J., Mulligan, R. C., and Carter, B. S. (2008) Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation. J. Neurosurg. 108, 979-988 (Pubitemid 351656847)
24. Tsatsaris, V., Goffin, F., and Foidart, J. M. (2004) Circulating angiogenic factors and preeclampsia. N. Engl. J. Med. 350, 2003-2004; author reply 2003-2004
25. Munaut, C., Lorquet, S., Pequeux, C., Blacher, S., Berndt, S., Frankenne, F., and Foidart, J. M. (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum. Reprod. 23, 1407-1415
26. Robak, E., Sysa-Jedrzejewska, A., and Robak, T. (2003) Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus. Mediators Inflamm. 12, 293-298
27. Wierzbowska, A., Robak, T., Wrzesien-Kus, A., Krawczynska, A., Lech-Maranda, E., and Urbanska-Rys, H. (2003) Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia. Eur. Cytokine Netw. 14, 149-153
28. Kearney, J. B., Kappas, N. C., Ellerstrom, C., DiPaola, F. W., and Bautch, V. L. (2004) The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 103, 4527-4535
29. Kappas, N. C., Zeng, G., Chappell, J. C., Kearney, J. B., Hazarika, S., Kallianos, K. G., Patterson, C., Annex, B. H., and Bautch, V. L. (2008) The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell Biol. 181, 847-858
30. Chappell, J. C., Taylor, S. M., Ferrara, N., and Bautch, V. L. (2009) Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev. Cell. 17, 377-386
31. Berndt, S., Perrier d'Hauterive , S., Blacher, S., Pequeux, C., Lorquet, S., Munaut, C., Applanat, M., Herve, M. A., Lamande, N., Corvol, P., van den Brule, F., Frankenne, F., Poutanen, M., Huhtaniemi, I., Geenen, V., Noel, A., and Foidart, J. M. (2006) Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 20, 2630-2632
32. Masson, V. V., Devy, L., Grignet-Debrus, C., Bernt, S., Bajou, K., Blacher, S., Roland, G., Chang, Y., Fong, T., Carmeliet, P., Foidart, J. M., and Noel, A. (2002) Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol. Proceed. Online 4, 24-31
33. Bruyere, F., Melen-Lamalle, L., Blacher, S., Roland, G., Thiry, M., Moons, L., Frankenne, F., Carmeliet, P., Alitalo, K., Libert, C., Sleeman, J. P., Foidart, J. M., and Noel, A. (2008) Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5, 431-437
34. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528
35. Yu, J., deMuinck, E. D., Zhuang, Z., Drinane, M., Kauser, K., Rubanyi, G. M., Qian, H. S., Murata, T., Escalante, B., and Sessa, W. C. (2005) Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc. Natl. Acad. Sci. U. S. A. 102, 10999-11004
36. Kashiwagi, S., Tsukada, K., Xu, L., Miyazaki, J., Kozin, S. V., Tyrrell, J. A., Sessa, W. C., Gerweck, L. E., Jain, R. K., and Fukumura, D. (2008) Perivascular nitric oxide gradients normalize tumor vasculature. Nat. Med. 14, 255-257
37. Igarashi, J., Bernier, S. G., and Michel, T. (2001) Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase: differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem. 276, 12420-12426
38. Allende, M. L., Yamashita, T., and Proia, R. L. (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102, 3665-3667
39. Igarashi, J., and Michel, T. (2008) S1P and eNOS regulation. Biochim. Biophys. Acta 1781, 489-495
40. Kendall, R. L., and Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U. S. A. 90, 10705-10709
41. Kamba, T., Tam, B. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., Anderson, K. D., Thurston, G., Joho, S., Springer, M. L., Kuo, C. J., and McDonald, D. M. (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 290, H560-H576
42. Roeckl, W., Hecht, D., Sztajer, H., Waltenberger, J., Yayon, A., and Weich, H. A. (1998) Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp. Cell. Res. 241, 161-170
43. Albuquerque, R. J., Hayashi, T., Cho, W. G., Kleinman, M. E., Dridi, S., Takeda, A., Baffi, J. Z., Yamada, K., Kaneko, H., Green, M. G., Chappell, J., Wilting, J., Weich, H. A., Yamagami, S., Amano, S., Mizuki, N., Alexander, J. S., Peterson, M. L., Brekken, R. A., Hirashima, M., Capoor, S., Usui, T., Ambati, B. K., and Ambati, J. (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 15, 1023-1030
44. Ferrara, N., and Kerbel, R. S. (2005) Angiogenesis as a therapeutic target. Nature 438, 967-974
45. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, K. A., and Curiel, D. T. (1998) Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. U. S. A. 95, 8795-8800
46. Dings, R. P., Loren, M., Heun, H., McNiel, E., Griffioen, A. W., Mayo, K. H., and Griffin, R. J. (2007) Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin. Cancer Res. 13, 3395-3402
47. Igarashi, J., Erwin, P. A., Dantas, A. P., Chen, H., and Michel, T. (2003) VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc. Natl. Acad. Sci. U. S. A. 100, 10664-10669
48. Rose-John, S., Scheller, J., Elson, G., and Jones, S. A. (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J. Leukoc. Biol. 80, 227-236
49. Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., and Iruela-Arispe, M. L. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703
50. Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R. S., Angle, N., and Cheresh, D. A. (2008) A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809-813